Suchergebnisse
Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates
Aspen Aerogels (ASPN) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.04 per share a year ago. These figures are adjusted
Watts Water Q2 Earnings Beat Estimates on Data Center Demand
Watts Water Technologies, Inc. WTS reported second-quarter 2026 adjusted earnings of $3.66 per share, up 18.4% from $3.09 a year ago. The bottom line beat the Zacks Consensus Estimate of $3.34 by
EBAY Q2 Earnings Beat Estimates on Higher GMV and Ad Growth
eBay EBAY reported second-quarter 2026 non-GAAP earnings of $1.6 per share, which beat the Zacks Consensus Estimate of $1.51 by 5.96%. The bottom line increased 16.8% year over year.Net revenues of
Starwood Property Trust (STWD) Q2 Earnings Meet Estimates
Starwood Property Trust (STWD) came out with quarterly earnings of $0.4 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.43 per share a year ago. These figures
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Misses Revenue Estimates
Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.24 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.41 per share a year ago. These figures are
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates
Nuvation Bio Inc. (NUVB) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.17 per share a year ago. These figures are
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.33 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.18 per share a year ago. These figures are
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates
Lexicon Pharmaceuticals (LXRX) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.01 per share a year ago. These figures are
FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates
FrontView REIT, Inc. (FVR) came out with quarterly funds from operations (FFO) of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.32 per share a year ago
Paycom's Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
Paycom Software, Inc. PAYC reported better-than-expected second-quarter 2026 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate.
The online payroll and human resource
Ormat Technologies Q2 Earnings and Revenues Beat Estimates
Ormat Technologies Inc. ORA reported second-quarter 2026 adjusted earnings per share of 50 cents, which beat the Zacks Consensus Estimate of 29 cents by 72.4%. The bottom line also increased 4.2%
Why Delta Air Lines (DAL) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
SNEX Q3 Earnings Top on Commercial and Institutional Gains, Stock Dips
StoneX Group Inc. (SNEX reported third-quarter fiscal 2026 earnings of $1.00 per share, which handily surpassed the Zacks Consensus Estimate of 76 cents. The bottom line jumped 85.2% year over
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark
United Therapeutics UTHR reported second-quarter 2026 earnings per share (EPS) of $7.27, beating the Zacks Consensus Estimate of $6.82. Bottom line increased 13.4% year over year.
United
MFC Q2 Earnings Beat on Asia Growth and Strong Insurance Sales
Manulife Financial Corporation MFC reported second-quarter 2026 core earnings of 79 cents per share, which beat the Zacks Consensus Estimate by 1.3%. The bottom line increased 16% year over year
Sempra's Q2 Earnings Outpace Estimates, Revenues Fall Y/Y
Sempra SRE reported second-quarter 2026 adjusted earnings per share (EPS) of $1.16, which beat the Zacks Consensus Estimate of $1.01 by 14.9%. The bottom line increased 30.3% from the year-ago
Allstate Q2 Earnings Beat Estimates on Higher Investment Income
The Allstate Corporation ALL reported a second-quarter 2026 adjusted net income of $8.99 per share, which outpaced the Zacks Consensus Estimate by 56.1%. The bottom line surged 51.3% year over year.
SPCX Shares Fall Despite Solid Q2 Results: Should You Pivot?
Space Exploration Technologies Corp. SPCX reported impressive second-quarter 2026 results with both the top and bottom lines surpassing the respective Zacks Consensus Estimate. Yet, SPCX shares




